| Noble Corp. Q4 2007 Earnings Call Transcript
2:00 PM ET Executives Lee M. Ahlstrom - VP, IR and Planning David W. Williams - Chairman, President, and CEO Thomas L. Mitchell - Sr. VP and CFO William C. (Kurt) Hoffman - VP, Worldwide Marketing Analysts Arun Jayaram - Credit Suisse Ian MacPherson - Simmons & Company Dan Pickering - Tudor, Pickering, Holt & Co. David Smith - J.P. Morgan Robin Shoemaker - Bear Stearns & Co. Roger Read - Natexis Bleichroeder Inc. Pierre E. Conner - Capital One Southcoast Inc. Collin Jerry - Raymond James & Associates Judson E. Bailey - Jefferies & Company William Sanchez - Howard Weil Inc. Geoff B. Kieburtz - Citigroup Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Noble Corporation Fourth Quarter and Full Year 2007 Earnings Conference Call. During the presentation, all participants will be in the listen-only mode.
Prep Profile: Danielle Ellingson, Madison Memorial
Year: Senior. Sports: Swimming, track and field. Fast facts: Ellingson is a three-time letterwinner and a two-time state qualifier in swimming for Memorial, which won the Big Eight Conference dual-meet title and will compete at the conference meet on Saturday. A co-captain as a senior, she is competing in the 100 breaststroke and 100 freestyle, 200 individual medley and 50 freestyle and 200 freestyle relay and 400 freestyle relay. As a junior, she was ninth in the 100 freestyle and 11th in the 50 freestyle at state for the Spartans, who finished third in the team competition. She also swam on the winning 200 freestyle relay and runner-up 400 freestyle relay that both earned All-America honors. Ellingson is a three-time letterwinner in track and field and competed at state in the 3,200 relay as a freshman.
Two Federal Public Health Grants Awarded To Weill Cornell Medical ...
Two major federal grants have been awarded to Public Health faculty at Weill Cornell Medical College in New York City.
Dr. Kenneth W. Griffin is the recipient of a three-year $1.6 million NIH grant from the National Institute on Drug Abuse (NIDA) for research into the long-term effects of a school-based drug-abuse prevention program previously delivered to urban minority youth attending New York City middle schools. The study will focus on a sample of approximately 3,500 young adults, ages 21 to 23, who participated in a randomized prevention trial during their early teens. In addition to testing the long-term effects of the prevention program on alcohol, tobacco and illicit drug use among the participants as young adults, the study will test whether the effects generalize to a variety of sexual risk behaviors.
|
